Tag: Clinical trials
Polatuzumab offers new hope for DLBCL patients on World Lymphoma Day
The first FDA-approved DLBCL treatment in nearly 20 years, Polatuzumab shows results in reducing relapse and disease progression
IQVIA conducts over 45 vaccine studies in India during last 5...
The company’s success in vaccine trials is driven by its extensive site network, comprising over 130 locations across India
Merck and Daiichi Sankyo collaborate on MK-6070 for global T-cell engager...
The new Agreement includes worldwide co-development and co-commercialization of DLL3 T-cell engager, excluding Japan
Agilisium earns AWS Life Sciences Competency Status, joining elite group of...
Agilisium's innovative GenAI-powered solutions recognized for transforming pharmaceutical R&D and accelerating drug discovery
Wider access to clinical trials necessary to democratize precision oncology: Report
While advancements in targeted therapies and biomarker discovery show promise, challenges like tumor complexity and unequal access remain
Anti-obesity drugs to dominate biopharma trends in 2024, reports GlobalData
Survey reveals obesity medications as key driver for industry growth in biopharmaceutical sector
Understanding Clinical Trials Landscape for Oncology in India
Closing gaps in clinical trial accessibility is vital to ensure equitable opportunities for diverse populations to benefit from advancements in cancer treatment
Triomics raises $15M to revolutionize oncology workflows with GenAI platform
San Francisco-based Triomics develops OncoLLMTM to automate critical processes in cancer centers, streamlining patient data processing and trial matching
Qila.io and Mascot Spincontrol collaborate to enhance transparency in clinical research...
The collaboration between Qila.io and Mascot Spincontrol aims to fortify data security and integrity in clinical trials, ushering in a new era of trust and transparency in healthcare research
World’s first comprehensive clinical trial unveils groundbreaking results in parkinson’s disease...
The results confirm that any therapy which the patient prefers, i.e. dance or music; along with meditation, has a definitive impact on the progress of the Parkinson’s disease and also on the quality of life of the patient